Home » Topics » Gastrointestinal, BioWorld Science

Gastrointestinal, BioWorld Science
RSS

Muscarinic receptor antagonists claimed by Pfizer for IBS, Alzheimer's disease

Oct. 30, 1997

Genome Therapeutics reaches milestone in H. pylori collaboration

Oct. 30, 1997

FDA clears generic cimetidine

Oct. 29, 1997

Hepatitis C-related technology available for licensing from NIH

Oct. 29, 1997

Shionogi presents potent and selective CCKB/gastrin receptor antagonist

Oct. 29, 1997

Cangene to manufacture new formulation of NABI's H-BIG

Oct. 28, 1997

IL-15 exerts potent antiapoptotic effects in vivo

Oct. 27, 1997

Anti-H. pylori cephems claimed by Fujisawa

Oct. 24, 1997

Janssen discloses agents that promote gastrointestinal motility

Oct. 24, 1997

Promising clinical trial results reported for Medeva's Hepagene as vaccine and treatment

Oct. 23, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 27, 2026.
Detecting the invisible: minimal residual disease at AACR 2026
BioWorld Science
Minimal residual disease (MRD) has become a central concept in modern oncology, reshaping how clinicians evaluate response, relapse risk and treatment precision....
A free gene therapy? Regeneron’s Otarmeni approved for hearing loss
BioWorld
Children and adults with a type of congenital hearing loss now have a free treatment option, with the U.S. FDA’s accelerated approval of Regeneron Pharmaceuticals...
AACR 2026: The age of agentic AI in oncology
BioWorld Science
New Approach Methodologies (NAMs) for drug development are transforming biomedical research by replacing or complementing animal models. More than 90% of...
Sichuan Kelun Pharmaceutical Research Institute discovers GPR6 inverse agonists
BioWorld Science
Sichuan Kelun Pharmaceutical Research Institute Co. Ltd. has identified G protein-coupled receptor 6 (GPR6) inverse agonists reported to be useful for the...